Dover just handed you a margin compression story dressed up in respectable revenue clothes, and most people are going to miss it entirely.
Dover just handed you a margin compression story dressed up in respectable revenue clothes, and most people are going to miss it entirely. Let's build the case.
Transcript
Dover just handed you a margin compression story dressed up in respectable revenue clothes, and most people are going to miss it entirely.
Let's build the case.
Start with the number that actually matters this quarter: operating margin at 14.9 percent. Sounds fine until you put it next to the trailing twelve-month figure sitting at 16.73 percent. That is nearly two full points of operating margin that evaporated in a single quarter. On a $2 billion revenue base, two points is not noise. That is roughly $40 million of operating income that walked out the door somewhere between the annual average and this print. The Street tends to anchor on the trailing twelve-month when they model forward — which means consensus entering this quarter likely assumed something closer to that 16-handle, not a 14.9 reality.
Now work up the income statement. Gross margin came in at 38.9 percent against a trailing twelve-month of 40.04. So the compression is happening at the top of the waterfall, not just in SG&A or R&D. Cost of revenue is eating into product economics, not just overhead. That distinction matters enormously. Overhead you can cut. Input costs and pricing power problems in the segments — those are structural until proven otherwise. When gross margin falls faster than operating margin relative to trailing periods, you want to know whether Dover is holding operating costs flat while the product margin erodes underneath. That is a slower bleed, and it is the kind that tends to persist through a cycle.
Then there is the EPS number that is genuinely alarming once you look at it the right way. Earnings per share growth on a trailing twelve-month year-over-year basis is down 51.65 percent. Revenue growth over the same window is a modest but positive 4 percent. Revenue growing, earnings cut in half. That divergence tells you the company is running harder to stay in place. Costs are scaling faster than the top line, margins are compressing at both the gross and operating level, and the net income conversion is deteriorating. Net margin this quarter came in at 11.6 percent versus the 13.3 trailing twelve-month. Every layer of the income statement is thinner than the recent run rate.
Now here is what I want you to think about with the valuation setup. Dover is trading at roughly 24.7 times trailing earnings and the forward multiple is around 20 times. That forward multiple implies the Street is modeling a meaningful earnings recovery — call it a reacceleration in the back half of the year — because if margins stay at this quarter's level, that forward number does not hold. The market is essentially pricing in a snapback. The question you have to ask is what drives it. Dover operates across industrial, climate and sustainability, clean energy, imaging, and pumping segments. Some of those have real secular demand tailwinds. But a secular tailwind does not automatically fix near-term margin pressure, especially if the compression is coming from input costs or pricing concessions in specific segments rather than volume softness you can recover with demand.
The 52-week range tells you one more thing worth sitting with. High of 237, low of 158. This stock has seen roughly a third of its value come off the peak. The filing lands you in a world where the margin trajectory is moving the wrong direction, the earnings power is demonstrably below where the trailing metrics suggest, and the valuation requires a recovery story to pencil out. That may be exactly what happens. But the filing does not show you the recovery. The filing shows you the compression.
That is the teardown. The numbers were always there — most people just do not look. See you at the next filing.